|
⚲
|
| Keyboard |
| Jones Hill Capital LP
✚
|
|
|---|---|
| CRD # | 339686 |
| SEC # | 801-135105 |
| CIK # | 0002102314 |
| AUM | 642.4 M (2026-05-06) |
| Employees | 8 (50% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-328-9320 |
| Address | 60 Charlton Street New York, NY 10013 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| BioMarin Pharmaceutical Inc | 71.7 | ||
| Vertex Pharmaceuticals Inc / Ma | 48.5 | ||
| Vaxcyte Inc | 37.5 | ||
| Nuvalent Inc | 30.8 | ||
| Nile Therapeutics Inc | 27.6 | ||
| Bicara Therapeutics Inc | 25.1 | ||
| Biosante Pharmaceuticals Inc | 24.5 | ||
| Ultragenyx Pharmaceutical Inc | 24.4 | ||
| Imara Inc | 23.2 | ||
| Amylyx Pharmaceuticals Inc | 22.2 | ||
| View All | |||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Jones Hill Capital Master Fund LP | [2025-12-05] | 230.3 M | |
| Filed 2026-01-16 (D) · Exemption 506(b), 3(c), 3(c)(7) · Minimum $100,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 8 | 642.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 8 | 642.4 |
| By Discretionary | ||
| Discretionary | 8 | 642.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 8 | 642.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 533.7 | |
| United States Persons | 108.7 | |
| Total | 8 | 642.4 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Christopher Meekins | Director | 3 | 3 | |
| Jones Hill Capital LP | Promoter | 2 | 2 | |
| Soren Gandrud | Executive Officer | 2 | 2 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0002102314] |
| Firm Profile (Form ADV) | |
|---|---|
| Serves | Institutional |
| Fund Types | Hedge Fund |
| LEI | 25490036SLH9ZR3QKG86 |
| Comparable Firms | State | AUM |
|---|---|---|
|
Polar Capital America Corporation
✚
|
FL | 656.1 M |
|
Rings Capital Management LLC
✚
|
IL | 653.0 M |
|
OCO Capital Partners LP
✚
|
NY | 651.8 M |
|
Guardian Point Capital LP
✚
|
VA | 646.4 M |
|
DAFNA Capital Management LLC
✚
|
CA | 645.2 M |
|
Karya Capital Management LLC
✚
|
NY | 643.5 M |
|
Stanley Capital Management LLC
✚
|
TX | 634.6 M |
|
Simcoe Capital Management LLC
✚
|
NY | 633.8 M |
|
G2 Investment Partners Management LLC
✚
|
NY | 630.2 M |
|
Solas Capital Management LLC
✚
|
CT | 629.0 M |